2 result(s) for BKM120
|PI Name||Protocol #||Title|
|Kathleen Kemmer||IRB00009076||A phase III randomized, double blind, placebo controlled study of BKM120 with fulvestrant, in postmenopausal women with hormone receptor-positive HER2-negative AI treated, locally advanced or metastatic breast cancer who progressed on or after mTOR inhibitor based treatment|
|Matthew Taylor||IRB00010630||CLGX818X2109: The LOGIC 2 trial, A phase II, multi-center, open-label study of sequential LGX818/MEK162 combination followed by a rational combination with targeted agents after progression, to overcome resistance in adult patients with locally advanced or metastatic BRAF V600 melanoma|
You may also qualify for Phase 1 Program trials.
For more information: